These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 219723)

  • 21. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW
    J Trop Pediatr; 1992 Feb; 38(1):17-21. PubMed ID: 1315397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal and perinatal outcomes of visceral leishmaniasis (kala-azar) treated with sodium stibogluconate in eastern Sudan.
    Adam GK; Abdulla MA; Ahmed AA; Adam I
    Int J Gynaecol Obstet; 2009 Dec; 107(3):208-10. PubMed ID: 19766208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Visceral leishmaniasis (Kala-Azar) in a 3-year-old German infant (author's transl)].
    Wittermann C; Bienzle U; Betke K
    Klin Padiatr; 1979 May; 191(3):311-7. PubMed ID: 222940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of visceral leishmaniasis in children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.
    Ritmeijer K; Veeken H; Melaku Y; Leal G; Amsalu R; Seaman J; Davidson RN
    Trans R Soc Trop Med Hyg; 2001; 95(6):668-72. PubMed ID: 11816442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India.
    Thakur CP; Olliaro P; Gothoskar S; Bhowmick S; Choudhury BK; Prasad S; Kumar M; Verma BB
    Trans R Soc Trop Med Hyg; 1992; 86(6):615-6. PubMed ID: 1337634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases.
    Thakur CP; Sinha GP; Pandey AK; Kumar N; Kumar P; Hassan SM; Narain S; Roy RK
    Ann Trop Med Parasitol; 1998 Jul; 92(5):561-9. PubMed ID: 9797829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
    Salih MAM; Fakiola M; Lyons PA; Younis BM; Musa AM; Elhassan AM; Anderson D; Syn G; Ibrahim ME; Blackwell JM; Mohamed HS
    Parasite Immunol; 2017 Jun; 39(6):. PubMed ID: 28370072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.
    Thakur CP; Kumar K; Sinha PK; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1987 Oct; 295(6603):886-7. PubMed ID: 2823955
    [No Abstract]   [Full Text] [Related]  

  • 31. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
    Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
    Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Visceral leishmaniasis (kala-azar). A rare differential diagnosis of splenomegaly and pancytopenia].
    Baldus M; Schleiffer T; Brass H
    Dtsch Med Wochenschr; 1989 Dec; 114(48):1876-81. PubMed ID: 2555125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW; Sondorp E; Winkler A
    Trans R Soc Trop Med Hyg; 1991; 85(3):365-9. PubMed ID: 1658990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observations on the effect of verapamil with sodium stibogluconate in kala azar.
    Thakur CP; Kumar M
    Trop Geogr Med; 1992 Jan; 44(1-2):15-8. PubMed ID: 1323160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The response of Kenyan kala-azar to treatment with sodium stibogluconate.
    Rees PH; Kager PA; Wellde BT; Hockmeyer WT
    Am J Trop Med Hyg; 1984 May; 33(3):357-61. PubMed ID: 6329010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India.
    Kumar Bhat N; Ahuja V; Dhar M; Ahmad S; Pandita N; Gupta V; Chandra S
    J Trop Pediatr; 2017 Apr; 63(2):104-108. PubMed ID: 27582128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.
    Herwaldt BL; Berman JD
    Am J Trop Med Hyg; 1992 Mar; 46(3):296-306. PubMed ID: 1313656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    Mengstie TA; Endale HT; Mulaw T; Abdella AM; Mohammed R; Malik T; Dessie G
    PLoS One; 2021; 16(10):e0257229. PubMed ID: 34597312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kala-azar imported from Yugoslavia].
    Rast HP; Marti HR
    Schweiz Med Wochenschr; 1986 Feb; 116(8):252-4. PubMed ID: 3006237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.